Identification & characterization of Shiga toxin-producing Escherichia coli isolates from patients with diarrhoea in Iran.

Background & objectives: Verotoxigenic Escherichia coli are important serotypes of enterohaemorrhagic E. coli (EHEC) subgroup that cause attaching and effacing lesions in enterocytes by producing verotoxins or shiga-like toxins resulting in haemorrhagic colitis (HC) and haemolytic uremic syndrome (HUS). The aim of this study was to detect these serotypes specially E. coli O157:H7 in stool samples of patients with diarrhoea and identification of virulence genes (STX1, STX2, Hly and EAE) in Shahrekord-Iran area using PCR technique. Methods: Two hundred diarrhoeal stool samples of patients were collected through 2007-2008. Microbiological and biochemical examinations were done to detect the E. coli. Serological tests carried out to identify the O157 or O157:H7 serotypes. Results: Of the 58 E. coli isolates, 16 (27.6%) were detected as STX1 carrying E. coli, four (6.9%) carrying STX2, eight (13.8%) carrying both STX1 and STX2, and 12 (20.7%) were Hly carrying E. coli, but none of the isolates contained EAE gene. None of the isolates were E. coli O157 or O157:H7 serotypes. Interpretation & conclusions: Our results revealed that verotoxigenic E. coli isolates other than O157 serotype were involved in causing diarrhoea in Shahrekord-Iran.

Síndrome hemolítico urémico asociado a infección por E. coli productor de toxina de shiga / Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome

E.coli productora de Toxina Shiga (STEC), también conocida como E.coli entero- hemorrágica (EHEC), provoca un amplio espectro de manifestaciones clínicas, ya sea en brote o en forma esporádica, que incluyen dolor abdominal, fiebre leve o ausente, con o sin vómitos, diarreas (sanguinolenta o no), y complicaciones extraintestinales como: síndrome hemolítico urémico (SHU) que se observa hasta en un 5-6 por ciento de niños infectados, y púrpura trombocitopénico (7 por ciento de adultos). EI principal factor de virulencia es la producción de una familia de moléculas denominada STX (Shiga toxin), de las cuales STX 1 y 2 son las más frecuentes y característica distintiva de estos E.coli. EI principal serogrupo involucrado en Chile es O157:H7 pero también se han aislado 026, 055, 02, 0117 y 06 (generalmente clasificadas como E. coli serogrupo clásico, no enterohemorrágico). Es fundamental para el clínico conocer la epidemiología, sintomatología y los exámenes que permitan un diagnóstico rápido para manejo terapéutico adecuado, y así evitar las complicaciones enunciadas anteriormente.

Shiga toxin producing E.coli (STEC), also known as enterohemorragic E.coli (EHEC), are responsible for a wide variety of clinical manifestations, both epidemic and sporadic. These include abdominal pain, no fever to mild fever, with or without vomits, diarrhea (bloody or not) and extraintestinal complications, such as haemolytic uremic syndrome in about 5 to 6 percent of children, and trombocitopenic purpura in 1 percent adults. The main virulence factor involved is the production of STX (Shiga toxin). In Chile there is marked prevalence of E.coli serogroup 0157 :H7 in these cases, although it has been associated also to E.coli 026, 055,02,0117 and 06, considered as classic serogroup (not enterohemorragic). It is of outmost importance for clinicians to be aware of symptoms and signs of this disease, as well as diagnostic methods that allow a prompt and adequate treatment, in order to avoid complications.

Papel de la Toxina Shiga en el sindrome urémico hemolítico / Role of the Shiga toxin in the hemolytic uremic syndrome

In the last years, infection associated with Shiga toxin-producing Escherichia coli (STEC) and subsequent Hemolitic-Uremic Syndrome (HUS) became relevant as a public health since it was considered as one of the most important emergent patogen present in the food contaminated by cattle feces. STEC infection may be asymptomatic or begins with a watery diarrhea that may or may not progress to bloody diarrhea (hemorrhagic colitis) and HUS. In Argentina, HUS is the most common pediatric cause of acute renal insufficiency and the second cause of chronic renal failure. Up to now, STEC infection lacks of known effective treatment strategies that diminish risk of progression to HUS. The mechanisms by which Shiga toxin (Stx) induce HUS may help to find strategies to prevent or ameliorate HUS. In this article, recent progress that has contributed to understanding the disease pathogenesis of STEC is reviewed. New strategies to prevent further uptake of Shiga from the gut, either during the diarrheal phase or once HUS has developed are discussed.